Lataa...
Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review
BACKGROUND: Convalescent plasma and hyperimmune immunoglobulin may reduce mortality in patients with viral respiratory diseases, and are being investigated as potential therapies for coronavirus disease 2019 (COVID‐19). A thorough understanding of the current body of evidence regarding benefits and...
Tallennettuna:
| Julkaisussa: | Cochrane Database Syst Rev |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley & Sons, Ltd
2021
|
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8135693/ https://ncbi.nlm.nih.gov/pubmed/34013969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013600.pub4 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|